We know from the Israel trial that this study should produce great results.
Note the reduction in tumour size - and this was from a single course of treatment ( normally there are two courses of treatment ).
- Forums
- ASX - By Stock
- Ann: Race Initiates Extramedullary AML Preclinical Study
We know from the Israel trial that this study should produce...
-
- There are more pages in this discussion • 138 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.55 |
Change
-0.030(1.90%) |
Mkt cap ! $267.6M |
Open | High | Low | Value | Volume |
$1.58 | $1.59 | $1.55 | $85.03K | 54.33K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 325 | $1.54 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.55 | 900 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 325 | 1.540 |
1 | 259 | 1.530 |
1 | 10000 | 1.525 |
1 | 2239 | 1.520 |
2 | 5661 | 1.510 |
Price($) | Vol. | No. |
---|---|---|
1.545 | 900 | 1 |
1.550 | 2685 | 2 |
1.560 | 3172 | 1 |
1.565 | 2401 | 1 |
1.570 | 4392 | 2 |
Last trade - 11.33am 11/11/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |
The Watchlist
3DA
AMAERO INTERNATIONAL LTD
Hank Holland, Executive Chairman and CEO
Hank Holland
Executive Chairman and CEO
SPONSORED BY The Market Online